Introduced at CES 2022, the Movano Ring is a smart ring that aims to one day provide FDA-cleared insights into chronic illnesses. The ring is currently undergoing clinical trials and accuracy studies for heart rate, SpO2, and respiratory rate with the aim of providing non-invasive glucose monitoring and cuffless blood pressure.
|
Scooped by
Richard Platt
onto Wearable Tech and the Internet of Things (Iot) December 28, 2021 6:40 PM
|
For CES 2022, health tech company Movano is announcing the Movano Ring, a wearable that aims to help people affordably monitor chronic illnesses and better understand their data. The Movano Ring will measure all the basic metrics, including heart rate, heart rate variability (HRV), sleep, respiration, temperature, blood oxygen levels, steps, and calories burned. However, instead of a raw data dump, Movano says it’ll distill how your metrics relate to each other “take a more proactive approach to mitigating the risks of chronic disease.” For example, the Movano app might tell you how your exercise habits impact your sleeping patterns or HRV over time. This isn’t surprising — more wearable makers are shifting away from steps and calories in favor of simplified scores and insights. The Oura Ring, Whoop, and Fitbit all use scores to contextualize sleep and recovery data but mostly focus on telling you whether to push yourself or take it easy on a given day. They’re also accompanied by graphs and lengthy descriptions that can, at times, be overwhelming. Movano says it wants its insights to be more actionable. So far, the app screenshots that Movano showed The Verge don’t show anything groundbreaking, but the way the data is presented is more digestible than many trackers out there.